REGULATED INFORMATION FMR LLC ANNOUNCE 9.10% SHAREHOLDING IN ABLYNX GHENT, Belgium, 18 November 2016 – Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of

Source URL: hugin.info

REGULATED INFORMATION ABLYNX ANNOUNCES RESULTS FOR THE FIRST NINE MONTHS OF 2016 AND A YEAR-TO-DATE BUSINESS UPDATE Strong clinical progress across our product portfolio GHENT, Belgium, 23 November 2016 – Ablynx [Euro

Source URL: hugin.info

ABLYNX ACHIEVES FIRST MILESTONE AS PART OF COLLABORATION WITH NOVO NORDISK   Multi-specific Nanobody candidate reached discovery milestone Ablynx to receive a €1 million success fee

Source URL: hugin.info

大正製薬-英字ロゴ

Source URL: www.ablynx.com

REGULATED INFORMATION ABLYNX ANNOUNCES HALF-YEAR RESULTS FOR 2015  Caplacizumab on track to enter Phase III in acquired TTP, with Ablynx committed to lead commercialisation in Europe and the USA  4 Phase II clinic

Source URL: hugin.info

ABLYNX TO HOST WEBCAST FOR ITS 2015 HALF-YEAR RESULTS ON 27 AUGUST GHENT, Belgium, 19 August 2015 – Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] will announce its half-year results for 2015 on Thursday 27 August 2015 a

Source URL: hugin.info

ABLYNX INITIATES A MULTINATIONAL PHASE III STUDY WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED TTP, A RARE BLOOD CLOTTING DISORDER    

Source URL: hugin.info

QUARTERLY IR NEWSLETTER Q3 2015 Issue No 18 COLLABORATION WITH MERCK & CO., INC. IN IMMUNO-ONCOLOGY SIGNIFICANTLY EXPANDED

Source URL: www.ablynx.com

ABLYNX ANNOUNCES PRESENTATIONS ON ITS POTENTIAL FIRST-IN-CLASS TREATMENT FOR ACQUIRED TTP, CAPLACIZUMAB, AT THE 2015 ANNUAL MEETING OF THE ISTH GHENT, Belgium, 17 JuneAblynx [Euronext Brussels: ABLX; OTC: ABYLY]

Source URL: hugin.info

LSP Life Sciences Fund September 2012.xls

Source URL: www.lspvc.com

• Vrije Universiteit Brussel
• Euronext
• Funds
• Financial services
• Financial economics
• Investment
• Ablynx